ArticleNPJ genomic medicine2019

A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity.

Mickael Rosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.